Health Catalyst CEO Retirement Announcement

Health Catalyst ( (HCAT) ) just unveiled an update.

On August 5, 2025, Health Catalyst announced that CEO Dan Burton plans to retire effective June 30, 2026, after 15 years of service. The company will conduct a search for a new CEO, while Burton will continue to serve on the Board. Additionally, Justin Spencer was appointed to the Board, effective September 1, 2025, expanding the Board to eight directors. Health Catalyst reported strong financial results for the second quarter of 2025, with a total revenue of $80.7 million and an Adjusted EBITDA of $9.3 million, surpassing their quarterly guidance. The company remains committed to achieving its goals and driving value for clients and shareholders during the leadership transition.

The most recent analyst rating on (HCAT) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Health Catalyst stock, see the HCAT Stock Forecast page.

Spark’s Take on HCAT Stock

According to Spark, TipRanks’ AI Analyst, HCAT is a Neutral.

The overall score reflects strong revenue growth and positive earnings call sentiment, offset by profitability challenges, bearish technical indicators, and valuation concerns. The strategic shift to the Ignite platform and successful client engagement are positives, but financial sustainability remains a key risk.

To see Spark’s full report on HCAT stock, click here.

More about Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services for healthcare organizations. The company offers a cloud-based technology ecosystem, AI-enabled data and analytics solutions, and expert services to drive clinical, financial, and operational improvements across patient records worldwide.

Average Trading Volume: 550,382

Technical Sentiment Signal: Sell

Current Market Cap: $265.9M

See more insights into HCAT stock on TipRanks’ Stock Analysis page.